NSAIDs and COVID-19: A New Challenging Area

NSAIDs and COVID-19: A New Challenging Area

Considering the recent controversies regarding the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Coronavirus disease 2019 (COVID-19) patients, and due to the limited published data in this field, we reviewed currently available evidence for the use of NSAIDs in viral respiratory tract inf...

Full description

Bibliographic Details
Main Authors: Hananeh Baradaran, Hadi Hamishehkar, Haleh Rezae
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2020-11-01
Series:Pharmaceutical Sciences
Subjects:
nsaids
covid-19
patients
Online Access:https://ps.tbzmed.ac.ir/PDF/ps-26-S49.pdf
id doaj-b0d4c2d24ea8442481e3ffa937bf56c8
record_format Article
spelling doaj-b0d4c2d24ea8442481e3ffa937bf56c82021-04-02T16:22:44ZengTabriz University of Medical SciencesPharmaceutical Sciences2383-28862020-11-0126Covid-19S49S5110.34172/PS.2020.41ps-33389NSAIDs and COVID-19: A New Challenging AreaHananeh Baradaran0Hadi Hamishehkar1Haleh Rezae2Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.Department of Clinical Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.Department of Clinical Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.Considering the recent controversies regarding the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Coronavirus disease 2019 (COVID-19) patients, and due to the limited published data in this field, we reviewed currently available evidence for the use of NSAIDs in viral respiratory tract infections to help make decisions in this area. Currently, there is insufficient evidence to judge the safety and efficacy of NSAIDs in patients with COVID-19. According to the current evidence, acetaminophen is the choice treatment for symptomatic relief. If the patients’ symptoms are not controlled by acetaminophen, naproxen may be used as an alternative therapy.https://ps.tbzmed.ac.ir/PDF/ps-26-S49.pdfnsaidscovid-19patients
collection DOAJ
language English
format Article
sources DOAJ
author Hananeh Baradaran
Hadi Hamishehkar
Haleh Rezae
spellingShingle Hananeh Baradaran
Hadi Hamishehkar
Haleh Rezae
NSAIDs and COVID-19: A New Challenging Area
Pharmaceutical Sciences
nsaids
covid-19
patients
author_facet Hananeh Baradaran
Hadi Hamishehkar
Haleh Rezae
author_sort Hananeh Baradaran
title NSAIDs and COVID-19: A New Challenging Area
title_short NSAIDs and COVID-19: A New Challenging Area
title_full NSAIDs and COVID-19: A New Challenging Area
title_fullStr NSAIDs and COVID-19: A New Challenging Area
title_full_unstemmed NSAIDs and COVID-19: A New Challenging Area
title_sort nsaids and covid-19: a new challenging area
publisher Tabriz University of Medical Sciences
series Pharmaceutical Sciences
issn 2383-2886
publishDate 2020-11-01
description Considering the recent controversies regarding the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Coronavirus disease 2019 (COVID-19) patients, and due to the limited published data in this field, we reviewed currently available evidence for the use of NSAIDs in viral respiratory tract infections to help make decisions in this area. Currently, there is insufficient evidence to judge the safety and efficacy of NSAIDs in patients with COVID-19. According to the current evidence, acetaminophen is the choice treatment for symptomatic relief. If the patients’ symptoms are not controlled by acetaminophen, naproxen may be used as an alternative therapy.
topic nsaids
covid-19
patients
url https://ps.tbzmed.ac.ir/PDF/ps-26-S49.pdf
work_keys_str_mv AT hananehbaradaran nsaidsandcovid19anewchallengingarea
AT hadihamishehkar nsaidsandcovid19anewchallengingarea
AT halehrezae nsaidsandcovid19anewchallengingarea
_version_ 1721556819130712064

Similar Items